カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の不活化ポリオ＆狂犬病ワクチン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Inactivated Polio and Rabies Vaccines Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19417）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19417
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：90
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の不活化ポリオ＆狂犬病ワクチン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

不活化ポリオ＆狂犬病ワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の不活化ポリオ＆狂犬病ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

不活化ポリオ＆狂犬病ワクチン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・不活化ポリオワクチン、不活化狂犬病ワクチン

用途別セグメントは次のように区分されます。
・小児科、成人

世界の不活化ポリオ＆狂犬病ワクチン市場の主要な市場プレーヤーは以下のとおりです。
・Bharat Biotech、BIO-MED、Serum Institute of India、Kedrion Biopharma、GlaxoSmithKline、Merck、Pfizer

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、不活化ポリオ＆狂犬病ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な不活化ポリオ＆狂犬病ワクチンメーカーの企業概要、2019年～2022年までの不活化ポリオ＆狂犬病ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な不活化ポリオ＆狂犬病ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別不活化ポリオ＆狂犬病ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの不活化ポリオ＆狂犬病ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での不活化ポリオ＆狂犬病ワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および不活化ポリオ＆狂犬病ワクチンの産業チェーンを掲載しています。
・第13、14、15章では、不活化ポリオ＆狂犬病ワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 不活化ポリオ＆狂犬病ワクチンの概要
- 種類別分析（2017年vs2021年vs2028年）：不活化ポリオワクチン、不活化狂犬病ワクチン
- 用途別分析（2017年vs2021年vs2028年）：小児科、成人
- 世界の不活化ポリオ＆狂犬病ワクチン市場規模・予測
- 世界の不活化ポリオ＆狂犬病ワクチン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Bharat Biotech、BIO-MED、Serum Institute of India、Kedrion Biopharma、GlaxoSmithKline、Merck、Pfizer
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：不活化ポリオワクチン、不活化狂犬病ワクチン
・用途別分析2017年-2028年：小児科、成人
・不活化ポリオ＆狂犬病ワクチンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・不活化ポリオ＆狂犬病ワクチンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・不活化ポリオ＆狂犬病ワクチンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・不活化ポリオ＆狂犬病ワクチンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・不活化ポリオ＆狂犬病ワクチンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Inactivated Polio and Rabies Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Inactivated Polio and Rabies Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Pediatrics accounting for % of the Inactivated Polio and Rabies Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Inactivated Polio Vaccine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Inactivated Polio and Rabies Vaccines include Bharat Biotech, BIO-MED, Serum Institute of India, Kedrion Biopharma, and GlaxoSmithKline, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Inactivated Polio and Rabies Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Inactivated Polio Vaccine
Inactivated Rabies Vaccine
Market segment by Application can be divided into
Pediatrics
Adults
The key market players for global Inactivated Polio and Rabies Vaccines market are listed below:
Bharat Biotech
BIO-MED
Serum Institute of India
Kedrion Biopharma
GlaxoSmithKline
Merck
Pfizer
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Inactivated Polio and Rabies Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Inactivated Polio and Rabies Vaccines, with price, sales, revenue and global market share of Inactivated Polio and Rabies Vaccines from 2019 to 2022.
Chapter 3, the Inactivated Polio and Rabies Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inactivated Polio and Rabies Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Inactivated Polio and Rabies Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Inactivated Polio and Rabies Vaccines.
Chapter 13, 14, and 15, to describe Inactivated Polio and Rabies Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Inactivated Polio and Rabies Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Inactivated Polio and Rabies Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Inactivated Polio Vaccine
1.2.3 Inactivated Rabies Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Inactivated Polio and Rabies Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pediatrics
1.3.3 Adults
1.4 Global Inactivated Polio and Rabies Vaccines Market Size & Forecast
1.4.1 Global Inactivated Polio and Rabies Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Inactivated Polio and Rabies Vaccines Sales in Volume (2017-2028)
1.4.3 Global Inactivated Polio and Rabies Vaccines Price (2017-2028)
1.5 Global Inactivated Polio and Rabies Vaccines Production Capacity Analysis
1.5.1 Global Inactivated Polio and Rabies Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Inactivated Polio and Rabies Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Inactivated Polio and Rabies Vaccines Market Drivers
1.6.2 Inactivated Polio and Rabies Vaccines Market Restraints
1.6.3 Inactivated Polio and Rabies Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Bharat Biotech
2.1.1 Bharat Biotech Details
2.1.2 Bharat Biotech Major Business
2.1.3 Bharat Biotech Inactivated Polio and Rabies Vaccines Product and Services
2.1.4 Bharat Biotech Inactivated Polio and Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 BIO-MED
2.2.1 BIO-MED Details
2.2.2 BIO-MED Major Business
2.2.3 BIO-MED Inactivated Polio and Rabies Vaccines Product and Services
2.2.4 BIO-MED Inactivated Polio and Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Serum Institute of India
2.3.1 Serum Institute of India Details
2.3.2 Serum Institute of India Major Business
2.3.3 Serum Institute of India Inactivated Polio and Rabies Vaccines Product and Services
2.3.4 Serum Institute of India Inactivated Polio and Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Kedrion Biopharma
2.4.1 Kedrion Biopharma Details
2.4.2 Kedrion Biopharma Major Business
2.4.3 Kedrion Biopharma Inactivated Polio and Rabies Vaccines Product and Services
2.4.4 Kedrion Biopharma Inactivated Polio and Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Inactivated Polio and Rabies Vaccines Product and Services
2.5.4 GlaxoSmithKline Inactivated Polio and Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Inactivated Polio and Rabies Vaccines Product and Services
2.6.4 Merck Inactivated Polio and Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Inactivated Polio and Rabies Vaccines Product and Services
2.7.4 Pfizer Inactivated Polio and Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Inactivated Polio and Rabies Vaccines Breakdown Data by Manufacturer
3.1 Global Inactivated Polio and Rabies Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Inactivated Polio and Rabies Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Inactivated Polio and Rabies Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Inactivated Polio and Rabies Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Inactivated Polio and Rabies Vaccines Manufacturer Market Share in 2021
3.5 Global Inactivated Polio and Rabies Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Inactivated Polio and Rabies Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Inactivated Polio and Rabies Vaccines Market Size by Region
4.1.1 Global Inactivated Polio and Rabies Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Inactivated Polio and Rabies Vaccines Revenue by Region (2017-2028)
4.2 North America Inactivated Polio and Rabies Vaccines Revenue (2017-2028)
4.3 Europe Inactivated Polio and Rabies Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Inactivated Polio and Rabies Vaccines Revenue (2017-2028)
4.5 South America Inactivated Polio and Rabies Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Inactivated Polio and Rabies Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Inactivated Polio and Rabies Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Inactivated Polio and Rabies Vaccines Revenue by Type (2017-2028)
5.3 Global Inactivated Polio and Rabies Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Inactivated Polio and Rabies Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Inactivated Polio and Rabies Vaccines Revenue by Application (2017-2028)
6.3 Global Inactivated Polio and Rabies Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Inactivated Polio and Rabies Vaccines Sales by Type (2017-2028)
7.2 North America Inactivated Polio and Rabies Vaccines Sales by Application (2017-2028)
7.3 North America Inactivated Polio and Rabies Vaccines Market Size by Country
7.3.1 North America Inactivated Polio and Rabies Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Inactivated Polio and Rabies Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Inactivated Polio and Rabies Vaccines Sales by Type (2017-2028)
8.2 Europe Inactivated Polio and Rabies Vaccines Sales by Application (2017-2028)
8.3 Europe Inactivated Polio and Rabies Vaccines Market Size by Country
8.3.1 Europe Inactivated Polio and Rabies Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Inactivated Polio and Rabies Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Inactivated Polio and Rabies Vaccines Market Size by Region
9.3.1 Asia-Pacific Inactivated Polio and Rabies Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Inactivated Polio and Rabies Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Inactivated Polio and Rabies Vaccines Sales by Type (2017-2028)
10.2 South America Inactivated Polio and Rabies Vaccines Sales by Application (2017-2028)
10.3 South America Inactivated Polio and Rabies Vaccines Market Size by Country
10.3.1 South America Inactivated Polio and Rabies Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Inactivated Polio and Rabies Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Inactivated Polio and Rabies Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Inactivated Polio and Rabies Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Inactivated Polio and Rabies Vaccines Market Size by Country
11.3.1 Middle East & Africa Inactivated Polio and Rabies Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Inactivated Polio and Rabies Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Inactivated Polio and Rabies Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Inactivated Polio and Rabies Vaccines
12.3 Inactivated Polio and Rabies Vaccines Production Process
12.4 Inactivated Polio and Rabies Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Inactivated Polio and Rabies Vaccines Typical Distributors
13.3 Inactivated Polio and Rabies Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Inactivated Polio and Rabies Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Inactivated Polio and Rabies Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 4. Bharat Biotech Major Business
Table 5. Bharat Biotech Inactivated Polio and Rabies Vaccines Product and Services
Table 6. Bharat Biotech Inactivated Polio and Rabies Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. BIO-MED Basic Information, Manufacturing Base and Competitors
Table 8. BIO-MED Major Business
Table 9. BIO-MED Inactivated Polio and Rabies Vaccines Product and Services
Table 10. BIO-MED Inactivated Polio and Rabies Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 12. Serum Institute of India Major Business
Table 13. Serum Institute of India Inactivated Polio and Rabies Vaccines Product and Services
Table 14. Serum Institute of India Inactivated Polio and Rabies Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Kedrion Biopharma Basic Information, Manufacturing Base and Competitors
Table 16. Kedrion Biopharma Major Business
Table 17. Kedrion Biopharma Inactivated Polio and Rabies Vaccines Product and Services
Table 18. Kedrion Biopharma Inactivated Polio and Rabies Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline Major Business
Table 21. GlaxoSmithKline Inactivated Polio and Rabies Vaccines Product and Services
Table 22. GlaxoSmithKline Inactivated Polio and Rabies Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Merck Basic Information, Manufacturing Base and Competitors
Table 24. Merck Major Business
Table 25. Merck Inactivated Polio and Rabies Vaccines Product and Services
Table 26. Merck Inactivated Polio and Rabies Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Pfizer Basic Information, Manufacturing Base and Competitors
Table 28. Pfizer Major Business
Table 29. Pfizer Inactivated Polio and Rabies Vaccines Product and Services
Table 30. Pfizer Inactivated Polio and Rabies Vaccines Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Inactivated Polio and Rabies Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 32. Global Inactivated Polio and Rabies Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Inactivated Polio and Rabies Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Inactivated Polio and Rabies Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Inactivated Polio and Rabies Vaccines Production Site of Key Manufacturer
Table 36. Inactivated Polio and Rabies Vaccines New Entrant and Capacity Expansion Plans
Table 37. Inactivated Polio and Rabies Vaccines Mergers & Acquisitions in the Past Five Years
Table 38. Global Inactivated Polio and Rabies Vaccines Sales by Region (2017-2022) & (K Units)
Table 39. Global Inactivated Polio and Rabies Vaccines Sales by Region (2023-2028) & (K Units)
Table 40. Global Inactivated Polio and Rabies Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Inactivated Polio and Rabies Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Inactivated Polio and Rabies Vaccines Sales by Type (2017-2022) & (K Units)
Table 43. Global Inactivated Polio and Rabies Vaccines Sales by Type (2023-2028) & (K Units)
Table 44. Global Inactivated Polio and Rabies Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Inactivated Polio and Rabies Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Inactivated Polio and Rabies Vaccines Price by Type (2017-2022) & (US$/Unit)
Table 47. Global Inactivated Polio and Rabies Vaccines Price by Type (2023-2028) & (US$/Unit)
Table 48. Global Inactivated Polio and Rabies Vaccines Sales by Application (2017-2022) & (K Units)
Table 49. Global Inactivated Polio and Rabies Vaccines Sales by Application (2023-2028) & (K Units)
Table 50. Global Inactivated Polio and Rabies Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Inactivated Polio and Rabies Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Inactivated Polio and Rabies Vaccines Price by Application (2017-2022) & (US$/Unit)
Table 53. Global Inactivated Polio and Rabies Vaccines Price by Application (2023-2028) & (US$/Unit)
Table 54. North America Inactivated Polio and Rabies Vaccines Sales by Country (2017-2022) & (K Units)
Table 55. North America Inactivated Polio and Rabies Vaccines Sales by Country (2023-2028) & (K Units)
Table 56. North America Inactivated Polio and Rabies Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Inactivated Polio and Rabies Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Inactivated Polio and Rabies Vaccines Sales by Type (2017-2022) & (K Units)
Table 59. North America Inactivated Polio and Rabies Vaccines Sales by Type (2023-2028) & (K Units)
Table 60. North America Inactivated Polio and Rabies Vaccines Sales by Application (2017-2022) & (K Units)
Table 61. North America Inactivated Polio and Rabies Vaccines Sales by Application (2023-2028) & (K Units)
Table 62. Europe Inactivated Polio and Rabies Vaccines Sales by Country (2017-2022) & (K Units)
Table 63. Europe Inactivated Polio and Rabies Vaccines Sales by Country (2023-2028) & (K Units)
Table 64. Europe Inactivated Polio and Rabies Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Inactivated Polio and Rabies Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Inactivated Polio and Rabies Vaccines Sales by Type (2017-2022) & (K Units)
Table 67. Europe Inactivated Polio and Rabies Vaccines Sales by Type (2023-2028) & (K Units)
Table 68. Europe Inactivated Polio and Rabies Vaccines Sales by Application (2017-2022) & (K Units)
Table 69. Europe Inactivated Polio and Rabies Vaccines Sales by Application (2023-2028) & (K Units)
Table 70. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Region (2017-2022) & (K Units)
Table 71. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Region (2023-2028) & (K Units)
Table 72. Asia-Pacific Inactivated Polio and Rabies Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Inactivated Polio and Rabies Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Type (2017-2022) & (K Units)
Table 75. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Type (2023-2028) & (K Units)
Table 76. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Application (2017-2022) & (K Units)
Table 77. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales by Application (2023-2028) & (K Units)
Table 78. South America Inactivated Polio and Rabies Vaccines Sales by Country (2017-2022) & (K Units)
Table 79. South America Inactivated Polio and Rabies Vaccines Sales by Country (2023-2028) & (K Units)
Table 80. South America Inactivated Polio and Rabies Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Inactivated Polio and Rabies Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Inactivated Polio and Rabies Vaccines Sales by Type (2017-2022) & (K Units)
Table 83. South America Inactivated Polio and Rabies Vaccines Sales by Type (2023-2028) & (K Units)
Table 84. South America Inactivated Polio and Rabies Vaccines Sales by Application (2017-2022) & (K Units)
Table 85. South America Inactivated Polio and Rabies Vaccines Sales by Application (2023-2028) & (K Units)
Table 86. Middle East & Africa Inactivated Polio and Rabies Vaccines Sales by Region (2017-2022) & (K Units)
Table 87. Middle East & Africa Inactivated Polio and Rabies Vaccines Sales by Region (2023-2028) & (K Units)
Table 88. Middle East & Africa Inactivated Polio and Rabies Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Inactivated Polio and Rabies Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Inactivated Polio and Rabies Vaccines Sales by Type (2017-2022) & (K Units)
Table 91. Middle East & Africa Inactivated Polio and Rabies Vaccines Sales by Type (2023-2028) & (K Units)
Table 92. Middle East & Africa Inactivated Polio and Rabies Vaccines Sales by Application (2017-2022) & (K Units)
Table 93. Middle East & Africa Inactivated Polio and Rabies Vaccines Sales by Application (2023-2028) & (K Units)
Table 94. Inactivated Polio and Rabies Vaccines Raw Material
Table 95. Key Manufacturers of Inactivated Polio and Rabies Vaccines Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Inactivated Polio and Rabies Vaccines Typical Distributors
Table 99. Inactivated Polio and Rabies Vaccines Typical Customers
List of Figures
Figure 1. Inactivated Polio and Rabies Vaccines Picture
Figure 2. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Type in 2021
Figure 3. Inactivated Polio Vaccine
Figure 4. Inactivated Rabies Vaccine
Figure 5. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Application in 2021
Figure 6. Pediatrics
Figure 7. Adults
Figure 8. Global Inactivated Polio and Rabies Vaccines Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Inactivated Polio and Rabies Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Inactivated Polio and Rabies Vaccines Sales (2017-2028) & (K Units)
Figure 11. Global Inactivated Polio and Rabies Vaccines Price (2017-2028) & (US$/Unit)
Figure 12. Global Inactivated Polio and Rabies Vaccines Production Capacity (2017-2028) & (K Units)
Figure 13. Global Inactivated Polio and Rabies Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Inactivated Polio and Rabies Vaccines Market Drivers
Figure 15. Inactivated Polio and Rabies Vaccines Market Restraints
Figure 16. Inactivated Polio and Rabies Vaccines Market Trends
Figure 17. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Manufacturer in 2021
Figure 18. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Manufacturer in 2021
Figure 19. Inactivated Polio and Rabies Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Inactivated Polio and Rabies Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Inactivated Polio and Rabies Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Region (2017-2028)
Figure 23. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Region (2017-2028)
Figure 24. North America Inactivated Polio and Rabies Vaccines Revenue (2017-2028) & (USD Million)
Figure 25. Europe Inactivated Polio and Rabies Vaccines Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Inactivated Polio and Rabies Vaccines Revenue (2017-2028) & (USD Million)
Figure 27. South America Inactivated Polio and Rabies Vaccines Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Inactivated Polio and Rabies Vaccines Revenue (2017-2028) & (USD Million)
Figure 29. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2017-2028)
Figure 30. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Type (2017-2028)
Figure 31. Global Inactivated Polio and Rabies Vaccines Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2017-2028)
Figure 33. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Application (2017-2028)
Figure 34. Global Inactivated Polio and Rabies Vaccines Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2017-2028)
Figure 36. North America Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2017-2028)
Figure 37. North America Inactivated Polio and Rabies Vaccines Sales Market Share by Country (2017-2028)
Figure 38. North America Inactivated Polio and Rabies Vaccines Revenue Market Share by Country (2017-2028)
Figure 39. United States Inactivated Polio and Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Inactivated Polio and Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Inactivated Polio and Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2017-2028)
Figure 43. Europe Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2017-2028)
Figure 44. Europe Inactivated Polio and Rabies Vaccines Sales Market Share by Country (2017-2028)
Figure 45. Europe Inactivated Polio and Rabies Vaccines Revenue Market Share by Country (2017-2028)
Figure 46. Germany Inactivated Polio and Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Inactivated Polio and Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Inactivated Polio and Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Inactivated Polio and Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Inactivated Polio and Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Inactivated Polio and Rabies Vaccines Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Inactivated Polio and Rabies Vaccines Revenue Market Share by Region (2017-2028)
Figure 55. China Inactivated Polio and Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Inactivated Polio and Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Inactivated Polio and Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Inactivated Polio and Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Inactivated Polio and Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Inactivated Polio and Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2017-2028)
Figure 62. South America Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2017-2028)
Figure 63. South America Inactivated Polio and Rabies Vaccines Sales Market Share by Country (2017-2028)
Figure 64. South America Inactivated Polio and Rabies Vaccines Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Inactivated Polio and Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Inactivated Polio and Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Inactivated Polio and Rabies Vaccines Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Inactivated Polio and Rabies Vaccines Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Inactivated Polio and Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Inactivated Polio and Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Inactivated Polio and Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Inactivated Polio and Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Inactivated Polio and Rabies Vaccines in 2021
Figure 76. Manufacturing Process Analysis of Inactivated Polio and Rabies Vaccines
Figure 77. Inactivated Polio and Rabies Vaccines Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 不活化ポリオワクチンの世界市場2023年：タイプⅠ、タイプⅡ、タイプⅢ
  • 世界の不活化ポリオワクチン市場2022年：市場規模予測（～2028年）
  • ポリオワクチンのグローバル市場展望 2023年-2029年：IPV、OPV
  • 世界の狂犬病抗血清市場2022年：市場規模予測（～2028年）
  • 世界のウマ狂犬病免疫グロブリン（ERIG）市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19417 )"世界の不活化ポリオ＆狂犬病ワクチン市場2022年：市場規模予測（～2028年）" (英文：Global Inactivated Polio and Rabies Vaccines Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。